Bad News on Anti-HER2 Heart Effects


<![CDATA[]]>(MedPage Today) — Cardiotoxicity related to trastuzumab (Herceptin) appeared to persist over a median follow-up of 7 years, a small cross-sectional, case-control study indicated. In 22 patients who developed cardiotoxicity… Source link